“3D MOLECULAR DOCKING COMBINED WITH AI-DRIVEN VIRTUAL SCREENING TO REPURPOSE FDA-APPROVED DRUGS FOR RARE NEURODEGENERATIVE DISEASES”. International Journal of Experimental Biology, vol. 2, no. 01, June 2024, pp. 50-73, https://ijeb.online/index.php/IJEB/article/view/23.